GBS(US:INBS) Globenewswireยท2025-05-15 13:00Core Insights - Intelligent Bio Solutions Inc. has surpassed 450 active accounts across 24 countries, driven by global demand for its fingerprint drug testing solutions [1][2][5] - The company added 35 new accounts in fiscal Q3, highlighting the growing adoption of its Intelligent Fingerprinting Drug Screening System, which provides results in under ten minutes [2][5] - The company is expanding into various sectors, including luxury marine, waste and recycling in Australia, and retail, indicating a strategic focus on high-demand markets [3][8] Company Growth and Expansion - Recent commercial milestones include entry into the luxury marine sector in Europe and expansion into regional testing programs in Australia [3] - The distributor network has grown to 19 countries through 18 partners, enhancing localized support and market access [4] - The company aims to strengthen its position in safety-critical industries, with plans for entry into the multi-billion-dollar U.S. market [5][6] Product and Technology - The Intelligent Fingerprinting Drug Screening System is designed for rapid, non-invasive testing, screening for drugs commonly found in the workplace [6] - The technology allows for sample collection in seconds and delivers results in under ten minutes, making it a valuable tool for employers [6] - The system's portability and ease of use are key factors driving its adoption across various industries [2][5]